Follow the latest coverage, related explainers and connected technology stories.
A study funded by Dexcom and published in the New England Journal of Medicine found that using the Dexcom G7 improved HbA1c levels and time in the target range among people with type 2 diabetes who do not use insulin. The findings come as Dexcom awaits a decision from CMS on expanding Medicare coverage for these devices.